Hard to say what the bottom would be here. Definitely will go upwards once they show postive cash flow, but until then, lots of expenses until full FDA approval. The issue is that we haven't seen significant positive cash flow with TGA approval and current sale initiatives. I think SP of about 22- 24 c would be fair value until we get further FDA approval
Hard to say what the bottom would be here. Definitely will go...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
-0.020(6.45%) |
Mkt cap ! $32.46M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 30.5¢ | 28.5¢ | $199.8K | 680.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 58285 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 3162 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |